Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints | NHLBI Trans-Omics for Precision Medicine Skip to main content

Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints

Short Name
ECLIPSE
Institution(s)
Harvard University
Type of Omics
WGS
Approx. Sample Size 2400 (ph3)
Disease/Phenotype
COPD
Starting Phase
Phase 3
dbGaP ID
TOPMed Accession #
Please see this TOPMed Project's Parent Studies.
Omics Center(s) Phase 3
McDonnell Genome Institute
Phases Involved
3
Populations
Adults Aged 40-75 with at least 10 Pack-years of Smoking
PI
Steering Committee Representatives
Project
ECLIPSE
Released
No
Back to top